Ranbaxy anti-asthmatic NCE gets nod for trials
Ranbaxy Laboratories Ltd has received the Regulatory approval for clinical Phase -I trials of its potentially anti-asthematic new chemical entity (NCE) code named RBx7796. The drug Controller's
Ranbaxy Laboratories Ltd has received the Regulatory approval for clinical Phase -I trials of its potentially anti-asthematic new chemical entity (NCE) code named RBx7796. The drug Controller's